Related Experiment Video
Updated: Oct 7, 2025
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.4K
Strong Predictive Algorithm of Pathogenesis-Based Biomarkers Improves Parkinson's Disease Diagnosis
Daniel Kam Yin Chan1,2,3, Nady Braidy4, Ren Fen Chen5
1University of New South Wales, Kensington, Australia. d.chan@unsw.edu.au.
Molecular Neurobiology
|January 7, 2022
Summary
New biomarkers, including alpha-synuclein and anti-alpha-synuclein, combined with amyloid beta-40, show promise for accurate Parkinson
Area of Science:
- Neuroscience
- Biochemistry
- Medical Diagnostics
Background:
- Parkinson's disease (PD) diagnosis can be challenging.
- Accessible and accurate biomarkers are needed to aid early and reliable diagnosis.
- Plasma-based biomarkers offer a minimally invasive approach.
Purpose of the Study:
- To investigate the diagnostic potential of plasma alpha-synuclein and anti-alpha-synuclein levels.
- To evaluate the utility of their ratios with amyloid beta-40 (Aβ40) for PD diagnosis.
- To develop and validate a diagnostic algorithm based on these biomarkers.
Main Methods:
- Quantification of plasma biomarkers (α-synuclein, anti-α-synuclein, Aβ40) using ELISA.
- Receiver Operating Characteristic (ROC) curve analysis to assess diagnostic performance.
- Development and verification of a two-step diagnostic algorithm in independent patient cohorts.
Main Results:
- Individual biomarkers and their ratios with Aβ40 demonstrated diagnostic potential.
- A two-step algorithm combining biomarker levels and ratios achieved high sensitivity (82%) and specificity (98%) in the training set.
- Independent verification confirmed high diagnostic accuracy, with sensitivity reaching 91.3% and specificity 90.5%.
Conclusions:
- A novel diagnostic algorithm integrating plasma α-synuclein, anti-α-synuclein, and their ratios with Aβ40 shows significant promise.
- This biomarker combination offers a sensitive and specific approach for Parkinson's disease diagnosis.
- The algorithm demonstrates effectiveness even in early-stage Parkinson's disease.
Related Concept Videos
01:15Parkinson's Disease: Overview
808
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
808
01:24Parkinson's Disease: Treatment
435
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
435
01:37Neural Regulation
40.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.5K